Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Investment
    • Tivity Health to buy...

    Tivity Health to buy Nutrisystem for Rs 140 crores

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 11 Dec 2018 3:45 AM  |  Updated On 11 Dec 2018 3:45 AM
    Tivity Health to buy Nutrisystem for Rs 140 crores

    New Delhi: Tivity Health Inc said recently it would buy diet plan developer Nutrisystem Inc for $1.4 billion(Rs 140 crores) in cash and stock, as it looks to expand its presence in the lucrative weight management market.


    Nutrisystem shareholders will get $38.75 per share in cash and 0.2141 Tivity Health shares for each share of Nutrisystem common stock, Tivity said.


    The company said it expects double-digit accretion to Tivity Health's adjusted earnings in 2020 and beyond, and annual cost savings of about $30 million to $35 million.


    Tivity works with health centres across the United States where it provides fitness and exercise programs, including one designed for seniors, while Nutrisystem designs weight loss plans and provides nutritious meals on order.


    Tivity plans to finance the cash portion of the acquisition, expected to close in the first quarter of 2019, with a fully committed term loan financing from Credit Suisse and existing cash on hand.


    Also Read: NBCC inks pact with Health Ministry to buy out HSCC

    AcquisitionbuycashCredit Suissediet plan developerexpandNutrisystemshareholderTivityTivity HealthTivity Health sharesUnited StatesUS
    Source : Reuters

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok